GlassScriptPhysician profile
Deborah D May
NPI 1407957855
$1,068.43
in general payments reported to CMS, 2019-2025
13 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $191 · 2023: $320 · 2024: $405 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $239.39 | 2024-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $190.85 | 2022-2024 | Ztlido |
| Nevro Corp. | $166.62 | 2022-2024 | Senza |
| Vertos Medical, INC. | $142.31 | 2023 | Mild Device Kit |
| Abbott Laboratories | $116.72 | 2024-2025 | Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.36 | 2023-2024 | Relistor |
| Globus Medical, INC. | $45.50 | 2025 | Senza |
| Medtronic, INC. | $18.53 | 2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $18.40 | 2024 | |
| Averitas Pharma INC. | $17.08 | 2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $16.13 | 2024 | |
| Almatica Pharma LLC | $16.06 | 2023 | Gralise |
| Kowa Pharmaceuticals America, INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.